Literature DB >> 3212936

Comparative drug metabolism and disposition in minor species.

C R Short1, S A Barker, W Flory.   

Abstract

The disposition of fenbendazole (FBZ) was studied in vivo in cattle (steers), goats, chickens, ducks, turkeys and rabbits, and in vitro in hepatic enzyme preparations from cattle, sheep, goats, rabbits, rats, chickens, ducks, turkeys and catfish. The major excretory metabolite when FBZ was administered either iv or po (5 mg/kg) was p-hydroxyfenbendazole (FBZ-OH). The sulfoxide (FBZ-SO) and sulfone (FBZ-SO2) appeared in plasma but were recovered in only trace amounts in urine or feces, and the amine (FBZ-NH2) was a minor metabolite appearing only occasionally in plasma. The greatest species differences were seen among the avian species, and differences in metabolite excretion correlated well with the ability of the species to metabolize the drug (especially to FBZ-OH) in vitro. Other in vitro studies measured the rate of oxidative, hydrolytic, and conjugative (glucuronide, acetate, sulfate) pathways in liver preparations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3212936

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  4 in total

1.  Interspecies considerations in the evaluation of human food safety for veterinary drugs.

Authors:  Arthur L Craigmill; Kristy A Cortright
Journal:  AAPS PharmSci       Date:  2002

2.  Effect of fenbendazole on three behavioral tests in male C57BL/6N mice.

Authors:  Bharathi S Gadad; João P L Daher; Eric K Hutchinson; Cory F Brayton; Ted M Dawson; Mikhail V Pletnikov; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

3.  Exacerbation of acetaminophen hepatotoxicity by the anthelmentic drug fenbendazole.

Authors:  Carol R Gardner; Vladimir Mishin; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2011-11-01       Impact factor: 4.849

4.  Old enemies, still with us after all these years.

Authors:  Charles B Clifford; Julie Watson
Journal:  ILAR J       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.